Compare McDonald's Corp (MCD) vs Koninklijke Philips NV (PHG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McDonald's Corp vs Koninklijke Philips NV — how do they compare? McDonald's Corp trades at $267.3 (market cap $190.16B), while Koninklijke Philips NV trades at $26.5 (market cap $26.19B). The key difference: McDonald's Corp is far larger — about 7.3× Koninklijke Philips NV's market cap, and Koninklijke Philips NV pays the higher dividend (3.79%). Which is the better fit depends on your goals.
| MCD | PHG | |
|---|---|---|
Market Cap | $190.16B | $26.19B |
Volume | 2,230,036 | — |
Sector | Consumer Cyclical | Health |
52-Week High | $341.06 | $32.91 |
52-Week Low | $264.54 | $24.54 |
Enterprise Value | $243.87B | $32.46B |
Dividend Yield | 2.78% | 3.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McDonald's stock trades at $267.64, down slightly by 0.03% on the day, and is currently in a bearish technical trend according to moving averages. The company reported Q1 2026 earnings that beat expectations with EPS of $2.83 versus $2.74 expected, and revenue growth remains steady, reaching $26.89 billion in 2025. Recent news highlights the launch of the 'McDonald's NEXT' growth strategy focusing on automation and improved customer experience to counter competitive pressures.
The outlook for McDonald's is supported by strong fundamentals including a high net income margin of 31.62% and a consensus analyst price target of $329, implying significant upside. However, risks include inflationary pressures on franchisee margins and high long-term debt of $38.42 billion. Investor sentiment is mixed with a bearish technical signal but optimistic analyst ratings, with 58% recommending buy.
PHG trades at $26.80, down 0.56% with bearish technical signals. The company shows improved fundamentals with net income turning positive to $895M in 2025 after previous losses, though revenue declined slightly to $17.83B. Analyst consensus is mixed with 40.9% buy ratings but technical indicators show selling pressure. Recent developments include FDA clearances for AI-powered medical devices and strategic healthcare partnerships.
PHG presents a turnaround story with profitability recovery but faces execution risks amid competitive pressures. The stock offers value at reasonable valuations (P/E 23.67, P/S 1.29) but requires monitoring of revenue stabilization and AI product adoption. Near-term catalyst includes Q2 2026 earnings with expected EPS of $0.40.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About McDonald's Corp
McDonald's Corporation franchises and operates fast-food restaurants in the global restaurant industry. The Company's restaurants serves a variety of value-priced menu products in countries around the world.
Read more on MCD →About Koninklijke Philips NV
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →
